Although research is still ongoing, many in the scientific community believe that CBD has the ability to serve a wide variety of medicinal purposes. Because the compound is non-psychoactive (meaning it will not get the user high) and can be derived from specially bred hemp legally, this essentially means that CBD could serve as medicinal marijuana…minus the marijuana. This is a slight exaggeration, as the THC compound in marijuana serves a wide variety of therapeutic purposes in it’s own right, but nevertheless – the increase in CBD research is certainly cause for excitement.
Over the past few decades, studies conducted in vitro and on animals have reported a number of promising developments. CBD is believed to posses the ability to reduce the severity of seizures, and has been touted as a potential treatment for epilepsy. Because CBD is non-psychoactive in nature, it is being extensively researched for potential use by epileptic children. Although there have not yet been enough clinical trials to prove CBD’s effectiveness beyond a doubt, the anecdotal evidence keeps piling up. A 2016 review in The New England Journal of Medicine stated that data has been compiled on patients with severe epilepsy since 2013 and that, using a hemp derived CBD treatment, the median reduction in the number of seizures was 54%. It is no wonder then that governments, pharmaceutical companies and university backed medical researchers have all been investing countless dollars towards studying CBD as a way to manage epilepsy.
On top of that, CBD has been proven to have neuroprotective properties, and may also be able to manage several neurodegenerative diseases, such as Alzheimer’s, multiple sclerosis and Parkinson’s disease. It is also being tested as a potential treatment for neurodegeneration caused by alcohol abuse as well as a way to treat heroin addiction. Much of the relevant research has been done on animals or in vitro, but there have been ongoing clinical trials which have shown successful developments.
CBD is also possibly an effective treatment of psychosis, and potentially schizophrenia, and has been more or less proven to reduce anxiety. In cannabis, CBD (which is non-psychoactive) has been proven to act as a counterbalance to THC (which is). It is believed that, in isolation, CBD may be able to have an even greater impact on the cannabinoid receptors (link to science of CBD article) than it does in concert with THC.
Although studies on the medicinal properties of cannabidiol are far from complete, the fact that it is non-psychoactive, legal (depending on the source) and proven to be 100 percent safe for human consumption, with virtually no notable side effects, has us excited for the future. If the successful developments found in recent research are any indication, it will only be a matter of time before CBD is a medically prescribed healing agent.
Visit www.cannaviri.con to stay up to date on recent developments in CBD research, as well as the latest cannabis and hemp news.
Although research is ongoing, recent developments suggest that cannabidiol could potentially be used to treat everything from epilepsy to back pain. Learn more about the medicinal future of CBD here: link